{"DataElement":{"publicId":"2002461","version":"3","preferredName":"Protocol COG Identifier Number","preferredDefinition":"the identification number assigned to each clinical protocol by COG.","longName":"PROT_COG_ID_NUM","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2196268","version":"1","preferredName":"Protocol Children's Oncology Group Identifier","preferredDefinition":"information related to the protocol ID Children's Cancer Group, an NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","longName":"PROT_COG_ID","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2223331","version":"1","preferredName":"Protocol","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.","longName":"C25320","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B105A-B8AD-27F8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2640380","version":"1","preferredName":"Children's Oncology Group Identifier","preferredDefinition":"The Children's Oncology Group (COG) is an NCI-supported clinical cooperative group (Arcadia, CA) formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C39353:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FEC361-F6C2-4B6C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-21","modifiedBy":"ONEDATA","dateModified":"2007-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE83C663-0138-3C45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018269","version":"1","preferredName":"Protocol COG Identifier Number","preferredDefinition":"the identification number assigned to a protocol by COG.","longName":"PROT_COG_ID_NUM","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008529","version":"1","preferredName":"Research Protocols","preferredDefinition":"the identification of cancer research protocols.","longName":"RSCH_PROT","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECC2BE-2F27-348A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184315","version":"1","preferredName":"Number","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"Number","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1E43-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2053B88-5ACE-69BC-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"CAMPBELB","dateModified":"2008-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811961","version":"1","longName":"Protocol/Admin.","context":"CTEP"}]}],"AlternateNames":[{"name":"20058282002461","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"COG Study No.","type":"Preferred Question Text","description":"COG Study No.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"COG Protocol Number","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"If Other, Specify protocol number:","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 2","type":"Alternate Question Text","description":"Specify COG Protocol Number:","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"Specify COG protocol number:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EE83BC8D-B786-4201-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-25","modifiedBy":"CHENR","dateModified":"2018-09-04","changeDescription":"DEC clean-up","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}